Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review

March 2021 | 66 pages | ID: L8B5BC7FB63EN
GlobalData

Abstracts

Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lonza Group Ltd (Lonza) is a contract manufacturing and development solutions provider. The company offers services including, commercial mammalian and microbial manufacturing, clinical development and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.

Lonza Group Ltd Key Recent Developments

Feb 23,2021: Lonza is recognised by Ethisphere as one of the world’s most ethical companies 2021
Feb 16,2021: Lonza expands solid form services for small molecule drugs
Jan 28,2021: Lonza announces high-quality cryopreserved leukopaks for more flexibility in immunology and cell therapy research
Jan 27,2021: Lonza reports strong 2020 performance, driven by sales growth in pharma and biotech business
Jan 15,2021: Invitation to Lonza’s Full-Year Results 2020 Conference Call and Webcast

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Lonza Group Ltd - Key Facts
Lonza Group Ltd - Key Employees
Lonza Group Ltd - Key Employee Biographies
Lonza Group Ltd - Major Products and Services
Lonza Group Ltd - History
Lonza Group Ltd - Company Statement
Lonza Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Lonza Group Ltd - Business Description
Business Segment: Pharma Biotech & Nutrition
Overview
Performance
Business Segment: Specialty Ingredients
Overview
Performance
R&D Overview
Lonza Group Ltd - Corporate Strategy
Lonza Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Lonza Group Ltd - Strengths
Lonza Group Ltd - Weaknesses
Lonza Group Ltd - Opportunities
Lonza Group Ltd - Threats
Lonza Group Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lonza Group Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 23, 2021: Lonza is recognised by Ethisphere as one of the world’s most ethical companies 2021
Feb 16, 2021: Lonza expands solid form services for small molecule drugs
Jan 28, 2021: Lonza announces high-quality cryopreserved leukopaks for more flexibility in immunology and cell therapy research
Jan 27, 2021: Lonza reports strong 2020 performance, driven by sales growth in pharma and biotech business
Jan 15, 2021: Invitation to Lonza’s Full-Year Results 2020 Conference Call and Webcast
Jan 14, 2021: Cytiva delivers modular biologics factory to Lonza
Dec 21, 2020: Lonza Expands Conjugation Facility with Two Additional Manufacturing Suites
Dec 10, 2020: Lonza announces broad selection of high-resolution HLA-typed primary cell lots to support biologic drug research
Dec 09, 2020: Lovelace Biomedical provides research to find new formulation for lung cancer treatment
Dec 02, 2020: Lonza announces customer-dedicated suites for commercialization of bioconjugates

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Lonza Group Ltd, Key Facts
Lonza Group Ltd, Key Employees
Lonza Group Ltd, Key Employee Biographies
Lonza Group Ltd, Major Products and Services
Lonza Group Ltd, History
Lonza Group Ltd, Subsidiaries
Lonza Group Ltd, Joint Venture
Lonza Group Ltd, Key Competitors
Lonza Group Ltd, Ratios based on current share price
Lonza Group Ltd, Annual Ratios
Lonza Group Ltd, Annual Ratios (Cont...1)
Lonza Group Ltd, Annual Ratios (Cont...2)
Lonza Group Ltd, Interim Ratios
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lonza Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Lonza Group Ltd, Performance Chart (2016 - 2020)
Lonza Group Ltd, Ratio Charts
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021